We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Details Five Postapproval Measures in Updated Guidance
EMA Details Five Postapproval Measures in Updated Guidance
June 19, 2013
The European Medicines Agency June 17 issued updated guidance on postmarketing authorization measures (PAM), spelling out five types of postapproval studies the agency may specify during review of a marketing authorization application.